V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011901 | 310005490 | 1.64 | 32.4 | Curative (C) | 2015-04-13 | 2016-05-29 | Trastuzumab Subcutaneous | 02 | N | 310005975 | IRINOTECAN + MDG |
| 310011902 | 310008433 | null | 64 | Curative (C) | null | 2015-03-29 | CISPLATIN + ETOPOSIDE | N | N | 310007558 | IPILIMUMAB + NIVOLUMAB |
| 310011903 | 310008474 | 1.69 | 57.6 | Curative (C) | 2019-03-16 | 2019-03-17 | MITOMYCIN | N | null | 310021471 | BENDAMUSTINE |
| 310011904 | 310005593 | 1.64 | 57 | Palliative (P) | null | 2016-07-02 | MITOMYCIN | N | N | 310022562 | ALEMTUZUMAB |
| 310011905 | 310005640 | 1.79 | 96.8 | Disease modification (D) | 2018-10-06 | 2018-10-12 | BEAM + Alemtuzumab Allo SCT | 02 | N | 310024263 | ALEMTUZUMAB |
| 310011906 | 310005670 | 1.5 | 61 | Palliative (P) | 2019-09-02 | 2019-09-23 | Bevacizumab+Carbo+Gemcitabine | N | N | 310025467 | DOXORUBICIN |
| 310011907 | 310005695 | 1.78 | null | Palliative (P) | 2017-05-18 | 2017-05-18 | METHOTREXATE | null | null | 310003715 | METHOTREXATE HIGH DOSE |
| 310011908 | 310002766 | 1.58 | 91.2 | Palliative (P) | 2020-07-26 | 2020-08-10 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | null | 310004157 | PACLITAXEL |
| 310011909 | 310002912 | 1.56 | 84.9 | Palliative (P) | 2015-04-29 | 2015-05-08 | Carboplatin + Paclitaxel (3 weekly) | N | N | 310004634 | CARBOPLATIN + PACLITAXEL |
| 310011910 | 310007191 | 1.52 | 75 | Palliative (P) | 2016-08-23 | 2016-09-21 | Paclitaxel 7 day | 02 | N | 310004655 | PACLITAXEL |
| 310011911 | 310002976 | 1.52 | 65.8 | Palliative (P) | 2018-10-15 | 2018-10-29 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 310004829 | CARBOPLATIN + PACLITAXEL |
| 310011912 | 310007215 | 1.59 | null | Palliative (P) | 2016-05-15 | 2016-07-05 | Carboplatin AUC 2 - 5 | null | null | 310004831 | CARBOPLATIN |
| 310011913 | 310003240 | 1.66 | 78.3 | Curative (C) | 2014-10-23 | 2014-10-23 | CHOP - 21 days | 2 | N | 310005683 | CHOP |
| 310011914 | 310003264 | 1.7 | 99.6 | Palliative (P) | 2015-12-01 | 2016-11-16 | GEMCARBO | N | N | 310005719 | GEMCARBO |
| 310011915 | 310003303 | 1.66 | 44.3 | Palliative (P) | 2020-03-28 | 2020-03-28 | Trial Unspecified | Y | N | 310005803 | TRIAL |
| 310011916 | 310011148 | null | null | null | 2015-05-21 | 2015-05-27 | Bevacizumab | 02 | N | 310006576 | BEVACIZUMAB |
| 310011917 | 310010583 | 1.75 | 69 | Palliative (P) | 2019-12-20 | 2019-12-27 | Liposomal Doxorubicin (20mg/m2) | N | N | 310007768 | LIPOSOMAL DOXORUBICIN |
| 310011918 | 310004194 | 1.55 | 63.6 | Curative (C) | 2018-04-30 | 2018-05-20 | CHOP | N | N | 310014972 | CHOP |
| 310011919 | 310004200 | 1.72 | 88.1 | Curative (C) | 2019-05-01 | 2019-05-10 | IVE | N | N | 310014991 | IVE |
| 310011921 | 310004627 | 1.74 | 70.2 | Curative (C) | 2019-09-25 | 2019-09-26 | Mini BEAM | N | N | 310018446 | BEAM |
| 310011922 | 310004638 | 1.68 | null | Palliative (P) | 2015-02-16 | 2015-02-16 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 310018467 | CISPLATIN + GEMCITABINE |
| 310011923 | 310004654 | null | null | Palliative (P) | 2017-09-04 | 2017-09-04 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018504 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011924 | 310004835 | 1.73 | 90.3 | Palliative (P) | 2018-09-27 | 2018-10-19 | Methotrexate intrathecal | N | N | 310019038 | METHOTREXATE INTRATHECAL |
| 310011925 | 310004912 | null | 60 | Palliative (P) | 2013-12-25 | 2014-04-28 | ESHAP | N | N | 310019371 | BEXAROTENE |
| 310011926 | 310009848 | 1.72 | 91.7 | null | 2016-07-29 | 2016-08-04 | Cisplatin | 02 | N | 310019677 | CISPLATIN |
| 310011927 | 310005267 | 1.5 | 62 | null | null | 2019-08-05 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | N | 310024633 | CYCLOPHOSPHAMIDE |
| 310011928 | 310008327 | null | 81 | Palliative (P) | 2016-08-12 | 2016-08-24 | Carboplatin + Docetaxel | 2 | N | 310024934 | TEMOZOLOMIDE |
| 310011929 | 310009947 | 1.53 | 71 | Palliative (P) | 2018-12-29 | 2019-09-02 | TRASTUZUMAB | 1 | N | 310024973 | TRABECTEDIN |
| 310011930 | 310005342 | 1.57 | 74.1 | Palliative (P) | 2017-09-09 | 2017-10-07 | NEOSCOPE TRIAL | N | N | 310025341 | HYDROXYCARBAMIDE |
| 310011931 | 310010828 | 1.57 | 68.9 | Curative (C) | 2017-02-05 | 2017-02-05 | IFOSFAMIDE + VINCRISTINE | 02 | N | 310025608 | TEMOZOLOMIDE |
| 310011932 | 310005393 | 1.76 | 49.9 | Adjuvant (A) | 2017-07-06 | 2017-07-10 | Cetuximab + Radiotherapy Maint | 02 | N | 310025719 | CAPECITABINE |
| 310011933 | 310005490 | 1.75 | 59.2 | Curative (C) | null | 2017-08-17 | METHOTREXATE + PEGASPARGASE | 02 | N | 310005975 | MERCAPTOPURINE + METHOTREXATE |
| 310011934 | 310005504 | 1.96 | null | Curative (C) | 2015-03-31 | 2015-04-24 | EP | 02 | N | 310007558 | IVA |
| 310011935 | 310010019 | null | 76.4 | Curative (C) | 2019-04-08 | 2019-09-09 | ICE (no GCSF) | N | N | 310021471 | DOXORUBICIN |
| 310011936 | 310005670 | 1.8 | null | Palliative (P) | 2019-10-21 | 2019-10-28 | Cisplatin + Etoposide (5 day) | N | N | 310025467 | IRINOTECAN + MDG |
| 310011937 | 310005696 | 1.67 | 73.8 | Palliative (P) | 2017-06-07 | 2017-06-08 | Capecitabine | null | null | 310003715 | AZACITIDINE |
| 310011938 | 310002767 | 1.53 | 68.3 | Palliative (P) | 2019-12-14 | 2021-02-01 | Paclitaxel 7 day | N | N | 310004157 | PACLITAXEL |
| 310011939 | 310007187 | null | null | Palliative (P) | 2015-06-09 | 2015-08-06 | Carboplatin AUC 2 - 5 | N | N | 310004634 | CARBOPLATIN |
| 310011940 | 310002976 | 1.76 | 89.3 | Palliative (P) | 2019-06-02 | 2019-06-14 | Liposomal Doxorubicin 50mg/m2 | N | null | 310004829 | LIPOSOMAL DOXORUBICIN |
| 310011941 | 310003241 | 1.7 | 86.6 | Palliative (P) | 2014-10-09 | 2014-10-23 | GemCarbo Days 1+8 | N | N | 310005683 | GEMCARBO |
| 310011942 | 310007317 | 1.53 | 92 | Curative (C) | 2016-11-14 | 2016-11-16 | Selumetinib | 1 | N | 310005719 | TRIAL |
| 310011943 | 310003820 | null | null | Palliative (P) | 2020-01-21 | 2020-01-21 | Trial Unspecified | 01 | N | 310007768 | TRIAL |
| 310011944 | 310004200 | null | 67.5 | Palliative (P) | 2017-09-01 | 2019-05-10 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310014991 | GEMCITABINE |
| 310011946 | 310004639 | 1.8 | null | Palliative (P) | 2015-09-07 | 2015-09-08 | PEMBROLIZUMAB | N | N | 310018467 | PEMBROLIZUMAB |
| 310011947 | 310007983 | 1.74 | 77 | Unknown (U) | 2017-11-29 | 2017-12-24 | Carboplatin + Liposomal Doxorubicin | 1 | N | 310018504 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011948 | 310004836 | null | 85 | Palliative (P) | 2019-04-23 | 2019-04-27 | PEMBROLIZUMAB | 2 | null | 310019038 | PEMBROLIZUMAB |
| 310011949 | 310005267 | 1.68 | 64.9 | Curative (C) | 2019-08-28 | 2019-09-04 | CISPLATIN + GEMCITABINE | N | N | 310024633 | CISPLATIN + GEMCITABINE |
| 310011950 | 310008327 | null | 82.6 | Curative (C) | 2016-12-13 | 2016-12-14 | Retinoblastoma Rel IA Melphalan | 02 | N | 310024934 | NOT MATCHED |
| 310011951 | 310005367 | 1.79 | 82 | Palliative (P) | 2017-02-18 | 2017-06-02 | CHLVPP | 2 | N | 310025608 | TRABECTEDIN |
| 310011952 | 310005671 | 1.8 | null | Palliative (P) | 2019-11-25 | 2019-12-01 | Y-90 | N | N | 310025467 | TRIPLE INTRATHECAL |